Analysts expect revenue increase Coloplast

Tomorrow the Danish Coloplast will report its past quarters results. For this year Coloplast 's (located in Humlebaek) revenue will be around 19.47 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 18.54 billion Danish Krone.

Historical revenues and results Coloplast plus estimates 2020

The analysts expect for 2021 a net profit of 4.78 billion Danish Krone. The majority of the analysts expects for this year a profit per share of 22.57 Danish Krone. So the price/earnings-ratio equals 45.17.

Per share the analysts expect a dividend of 19.37 Danish Krone per share. The dividend yield is then 1.9 percent. The average dividend yield of the pharmaceutical companies equals a moderate 1.39 percent.

Coloplast 's market capitalization is based on the number of outstanding shares around 198.21 billion Danish Krone. The Coloplast stock was the past 12 months quite volatile. Since last May the stock is 2 percent lower. This year the stock price moved between 855 and 1149 DKK.

Historical stock prices Coloplast

At 11.19 the stock trades 1.47 percent higher at 1019.5 Danish Krone.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.